InsiderSource
KALV

KalVista Pharmaceuticals, Inc.

SEC CIK 1348911
$27.00 +80.2% · 90 days
90-day buys
$0
0 open-market
90-day sells
$1.66M
12 open-market
Net insider flow
−$1.66M
Net selling
Filings shown
29
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at KALV have sold a net $1.66M of stock (0 open-market buys vs 12 sells).

Largest recent trade: Yea Christopher sold $905.2K of KALV, trimming their stake 13%.

Most active filer: Yea Christopher, with 9 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for KALV, newest first
View on SEC EDGAR ↗
Advertisement
KALV
KalVista Pharmaceuticals, Inc.
Sell Yea Christopher · CHIEF DEVELOPMENT OFFICER · Open-market sale · filed 2w ago ΔOwn −13%

Yea Christopher sold $905.2K of KALV, trimming their stake 13%.

−$905.2K
33,800 sh @ $27
KALV
KalVista Pharmaceuticals, Inc.
Sell Sweeny Nicole · Chief Commercial Officer · Open-market sale · filed 2w ago ΔOwn −2.4%

Sweeny Nicole sold $39.9K of KALV, trimming their stake 2%.

−$39.9K
1,489 sh @ $27
KALV
KalVista Pharmaceuticals, Inc.
Sell Sweeny Nicole · Chief Commercial Officer · Open-market sale · filed 2w ago ΔOwn −3.2%

Sweeny Nicole sold $49.8K of KALV, trimming their stake 3%.

−$49.8K
1,861 sh @ $27
KALV
KalVista Pharmaceuticals, Inc.
Sell Piekos Brian · Chief Financial Officer · Open-market sale · filed 2w ago ΔOwn −6.4%

Piekos Brian sold $39.9K of KALV, trimming their stake 6%.

−$39.9K
1,489 sh @ $27
Advertisement

About KALV insider activity

This page tracks every recent Form 4 filed for KalVista Pharmaceuticals, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is KALV insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for KalVista Pharmaceuticals, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.